Key facts
- Notable investors include Bpifrance, IRD Invest, Unigrains (Paris), Nord Est Partenaires.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Staphyt
- ·The full record, as it builds
Funding rounds
No funding rounds for Staphyt are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Staphyt
Provider of agroscience and regulatory affairs services intended to guide clients through the development and commercialization of their products. The company's platform offers customized services for agricultural research, laboratory testing, and regulatory affairs consultancy, benefiting users by ensuring product quality and compliance, enabling customers to successfully register and commercialize their substances, varieties, and products.
- Sector
- Business Products and Services (B2B)
- HQ
- Inchy-en-Artois, France
- Founded
- 1989
- Employees
- 600
- Website
- staphyt.com/
- Ownership
- Privately Held (backing)
Staphyt doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Staphyt shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Staphyt in its N-PORT filings yet. We sweep new filings monthly.